Atrial Fibrillation Support

A patient with AF is 5 times more likely to have a stroke, with AF related strokes resulting in increased rates of mortality, morbidity and disability.

Effective detection and preventative anticoagulation therapy can prevent an estimated 7,000 strokes and 2,000 premature deaths every year and save NHS resources.

Our pharmacist-led service can:

• Increase the numbers of patients with AF who are effectively anticoagulated and therefore practice achievement of QOF indicator AF007
• Provide patient-centred consultations to educate and support patients in the safe use of anticoagulants
• Facilitate transition or initiation of DOAC therapy as required to optimise safe and effective treatment
• Align with NHS clinical guide on use of DOACs during the coronavirus pandemic

Patients with AF who have a high risk of stroke but are not anticoagulated will be reviewed with action plans put into place to help manage their risk effectively. Patients with AF and anticoagulated with warfarin whose time in therapeutic range (TTR) is less than that recommended by best practice guidance will also be reviewed to bring in line with guidance.

Additionally, any patients with AF on a DOAC with clinical issues e.g. non-compliant, unlicensed dose can be reviewed to support long-term management.